SLCOG Clinical Practice Guideline

Preoperative Assessment and Immediate Postoperative Care for Lower Segment Caesarean Section (LSCS)

Guideline 27June 2026Perioperative care19 tables2 figures
Open source document

2. Scope

Table 3
IncludedExcluded / requires separate protocol
All four categories of caesarean section in maternity units.Detailed intraoperative surgical technique, except safety steps that directly affect postoperative care.
Preoperative counselling, consent, investigations, anaesthetic assessment and theatre readiness.Comprehensive placenta accreta spectrum operative management protocols. Suspected PAS requires senior multidisciplinary planning.
Immediate postoperative recovery, monitoring, analgesia, early feeding, mobilisation, VTE prevention, wound care and discharge readiness.Long-term postnatal follow-up beyond routine discharge planning.

3. Key standards

4. Risk stratification and team allocation

Risk stratification must be completed before elective LSCS and as early as possible after the decision for emergency LSCS.

Use this guide during preoperative planning and at the time of decision for LSCS. Identify the level of surgical expertise accordingly. Move to a higher level when uncertainty exists or when clinical risk evolves.

Level I: Standard caesarean delivery

Table 4
Required team/resourcesClinical examples
Experienced postgraduate trainee, Medical Officer/ senior house officer under the supervision of a Consultant Obstetrician.Breech, transverse lie or unstable lie; multiple pregnancy; posterior low-lying placenta; repeat caesarean delivery <=3 with no suspected placental abnormalities; maternal request; maternal infection such as primary genital herpes or HIV; diabetes with polyhydramnios or fetal macrosomia; fetal anomaly; previous major shoulder dystocia or previous third-/fourth-degree tear.

Level II: Specialist caesarean delivery

Table 5
Required team/resourcesClinical examples
Consultant obstetrician. Blood products immediately available for anterior placenta praevia or high haemorrhage risk. Urology/general surgery available as required.Placenta praevia; lower-segment fibroid; very premature caesarean birth <28 weeks for severe FGR requiring possible classical incision; repeat caesarean delivery >=4; repeat caesarean delivery with ultrasound/MRI evidence of major lower-segment remodelling; prior major abdominal, bladder, bowel or uterine reconstruction surgery; patients with renal transplant or pelvic kidney.

Level III: Multidisciplinary-team caesarean delivery

Table 6
Required team/resourcesClinical examples
Senior Obstetrician experienced in PAS surgery or Two Consultant Obstetricians. Senior Anaesthetist; immediate blood products; neonatal team; HDU/ICU access. Urology/general/vascular/interventional radiology support according to anticipated complications.Placenta praevia covering the cervix in a woman with previous caesarean delivery; anterior low-lying placenta or placenta praevia with ultrasound/MRI evidence of major lower-segment remodelling; low-lying placenta or placenta praevia with imaging signs of PAS.

5. Preoperative assessment and preparation

Use Annexure 1 as a structured counselling aid when discussing comparative risks of caesarean and vaginal birth.

5.2 Medical history and clinical examination

Table 7
Assessment domainMinimum required content
Obstetric historyParity, previous caesarean births, previous uterine surgery, previous PPH, placenta praevia/PAS risk, indication for current LSCS and urgency.
Medical historyDiabetes Mellitus, hypertension/pre-eclampsia, cardiac disease, asthma/respiratory disease, renal disease, bleeding or thrombotic disorders, sepsis, recent pyrexia and other relevant comorbidities.
Anaesthetic historyPrevious spinal/epidural/general anaesthesia, difficult airway, aspiration risk, anaesthetic complications, neuraxial contraindications, anticoagulant timing and family history of anaesthetic complications.
Medication and allergy reviewCurrent medicines, antiplatelets/anticoagulants, insulin or oral hypoglycaemics, antihypertensives, steroids and documented drug/latex/skin-prep allergies.
General examinationAnaemia, jaundice, non-dependent oedema, hydration status, airway concerns and venous access.
Vital signsTemperature, pulse, blood pressure, respiratory rate, oxygen saturation and level of consciousness. Use MEOWS chart where available.
Abdominal/obstetric assessmentFundal height, fetal lie/presentation, uterine tenderness, contractions, scar tenderness where relevant, fetal heart rate and antenatal records on placental location.
Cardiorespiratory assessmentFocused cardiovascular and respiratory examination for women with comorbidities, symptoms or abnormal vital signs.

5.3 Essential investigations

Table 8
InvestigationIndication
Full blood countTo identify any anaemia and thrombocytopaenia. Assess haemoglobin and platelet count before surgery. Repeat if there is bleeding, pre-eclampsia, sepsis, anaemia or recent clinical deterioration.
Blood group and save and crossmatch whenever necessaryPrepare for potential transfusion needs required for LSCS. Follow the local protocols for grouping and crossmatch according to haemorrhage risk, anaemia, placenta praevia/PAS risk, multiple previous caesareans or local transfusion policy.
Infection screeningUpdate HIV, syphilis and Hepatitis B nationally recommended antenatal infection screens if not previously completed or if results are unavailable.
Ultrasound informationDocument fetal lie and presentation, placental site, estimated fetal weight where relevant and any suspicion of PAS or lower-segment complexity.
ECGECG if clinically indicated.
Additional testsIndividualise: renal/liver profile, coagulation, blood glucose/ketones, pre-eclampsia bloods, crossmatched blood products or imaging depending on clinical risk.

5.4 Family planning and contraception

Before planned LSCS and emergency LSCS where feasible, review postpartum contraception and family-planning preferences. Document counselling on birth spacing, future pregnancy risks after caesarean birth and any agreed method such as postpartum intrauterine contraception or sterilisation.

5.5 Anaesthetic consultation and planning

5.6 Preoperative preparation checklist

Table 9
TaskStandard action
Fasting6 hours for solid food and 2 hours for clear fluids (excluding milk), unless urgency requires modified anaesthetic risk management.
Aspiration prophylaxisGive histamine (H2) receptor antagonists or PPI and prokinetic agents. For elective LCSC: Ranitidine 150 mg oral or omeprazole 20 - 40 mg oral, minimum of 2 doses with an 8-10 hour gap in between doses, second dose 2 hours before the LSCS. Add metoclopramide 10 mg oral with the second dose of the above. For emergency LSCS : Ranitidine 50 mg diluted in 10 ml distilled water slow IV or omeprazole 40 mg IV with metoclopramide 10 mg slow IV are to be given at the time of decision making. 0.3M Na citrate 15 ml orally should be given at theatre 30 mins prior to anesthesia. (Medication and doses may change according to availability).
Medication managementContinue essential medicines unless contraindicated. Adjust insulin, oral hypoglycaemics, anticoagulants, antiplatelets and antihypertensives according to anaesthetic/obstetric and haematologist plan.
IV accessPlacement of an intravenous (IV) cannula 16- 18 G for fluid administration is preferably done in OT for elective cases
Urinary catheterPlacement of a Foley catheter to drain the bladder in OT under anaesthesia and monitor urine output.
Skin preparationUse 2% chlorhexidine skin preparation unless contraindicated. Use an approved alternative in case of an allergy. In elective LSCS, it is a good practice to advice the patient to have a bath with soap and clean water prior to the commensement of surgical preparations.
Vaginal preparationFor ruptured membranes, consider aqueous povidone-iodine vaginal preparation to reduce endometritis risk; use aqueous chlorhexidine if povidone-iodine is unavailable or contraindicated.
Sedation and bowel preparationAvoid routine maternal sedation and routine bowel preparation, according to ERAS. Use only for clear clinical indications.
Patient preferencesWhere safe, accommodate a companion and patient preferences such as music,prayers or immediate bonding practices.

5.7 Prophylactic measures

Table 10
Risk areaRequired action
Antibiotic prophylaxisAdminister prophylactic antibiotics before skin incision. Preferably IV cefuroxime 1.5g or IV co-amoxiclav 1.2g. In case of a penicillin allergy, use IV clindamycin 600 mg single dose. Use the hospital-approved regimen active against endometritis, urinary-tract infection and wound infection. Record drug, dose and time. Repeat the antibiotics if operative duration exceeds 4 hours or estimated blood loss >1500 mL. (Please refer to Empirical and Prophylactic use of Antimicrobials, National Guidelines, Sri Lanka, 2024)
ThromboprophylaxisComplete VTE risk assessment for every woman. Use hydration, early mobilisation, mechanical prophylaxis and LMWH according to risk and local policy. Use pharmacological prophylaxis after bleeding-risk review and consultation of the obstetrician. (Please refer to Guideline on Prevention and Treatment of Venous-Thromboembolism in Obstetrics and Gynaecology in Sri Lanka, 2025 published by SLCOG).
Hypothermia preventionMaintain normothermia. Warm IV fluids and blood and blood products when volumes are significant and use warming measures when massive transfusion is indicated.
Haemorrhage readinessFor high-risk cases, ensure cross-matched blood, uterotonics, tranexamic acid access, cell salvage where available, senior help and massive transfusion activation pathway.
Prevention of neonatal anemiaDelayed cord clamping unless contraindicated and if time permits in prematurity.

5.8 Psychological and social support

5.9 WHO surgical safety checklist and theatre handover

The WHO Surgical Safety Checklist, adapted for local caesarean practice, must be completed at three points: before induction of anaesthesia, before skin incision and before the woman leaves the operating room. Use Annexure 2 as the standard checklist framework.

6. Immediate postoperative care

6.1 Transfer from theatre and structured handover

Before transfer from theatre to recovery or ward, the operating, anaesthetic and nursing teams should complete a structured handover. Minimum handover content is shown below.

Table 11
DomainHandover content
Procedure and indicationType of LSCS, urgency category, intraoperative findings and any additional procedure performed.
AnaesthesiaType of anaesthesia, neuraxial opioid used, airway concerns, conversion to general anaesthesia and plan for monitoring.
Haemorrhage and fluidsEstimated blood loss, uterotonics, tranexamic acid, IV fluids, transfusion, urine output and ongoing bleeding concerns.
Wound and drainsSkin closure method, dressing type, drains if any and wound-specific instructions.
MedicationsAntibiotics given, analgesia plan, VTE prophylaxis plan, antiemetics, antihypertensives/ hypoglycemic agents and medications to withhold/ restart.
Baby and breastfeedingNeonatal condition, skin-to-skin contact completed or deferred, breastfeeding initiation and neonatal review needs.
Escalation planMEOWS triggers, senior review criteria, HDU/ICU requirement and follow-up blood tests.

6.2 Recovery monitoring

Table 12
Clinical situationMinimum monitoring standard
After spinal or epidural anaesthesiaContinuous one-to-one observation until haemodynamically stable with regards to pulse, blood pressure and oxygen saturation. Then continue observations according to MEOWS chart (Annexure 4).
After general anaesthesiaAirway-skilled healthcare professional to provide continuous one-to-one observation until airway control is regained and the patient is able to communicate. Monitor vitals (oxygen saturation, heart rate, blood pressure) frequently for 30 minutes , every 15 minutes for 2 hours every 30 minutes for 2 hours.
After intrathecal/epidural opioid with respiratory-depression risk factorsHourly oxygen saturation, respiratory rate and sedation score for at least 12 hours, then routine postnatal observations unless clinical concerns persist.
Routine postoperative checksAssess vaginal bleeding, uterine tone, fundal level, urine output and wound dressing.
Complication surveillanceActively look for haemorrhage, uterine atony, sepsis, anaesthetic complications, urinary retention/injury, thromboembolism and severe pain requiring reassessment.

6.3 Pain management

Use Multimodal Analgesia. Prescribe baseline analgesics regularly rather than only as required.

Table 13
StepPreferred approach
1. Baseline analgesiaUse a combination of analgesics according to the patient requirement to manage pain while minimizing side effects. Subsequent analgesics can be added in the following order. Paracetamol preparation 1g 6 hourly after oral intake initiated (Ibuprofen 400mg tds is an alternative). Diclofenac Na 50 - 100 mg PR at theater if no contraindications or allergies. Subsequently 50mg up to 3 times a day. NSAIDs should be avoided or used with caution in women with active bleeding or high haemorrhage risk, renal impairment, severe pre-eclampsia with renal involvement, thrombocytopaenia or platelet dysfunction, active peptic ulcer disease, NSAID allergy, asthma or other relevant contraindications. Consider gastric protection in women at increased gastrointestinal risk.
2. Rescue AnalgesiaOral Tramadol 50 mg up to 3 times a day. S/C Morphine 0.1 mg/kg PRN (max 6 hourly). Add Ondansetron 4-8 mg 8 hourly.
3. Injectable opioid / Patient-Controlled Analgesia (PCA)For breakthrough pain, inability to tolerate oral medication or after general anaesthesia, consider IV/IM/SC morphine or IV PCA according to anaesthetic pain protocol. Monitor oxygen saturation, respiratory rate, sedation and pain score hourly while PCA is running and for at least 2 hours after stopping.
4. Side-effect preventionPrescribe antiemetics when needed and laxatives for women receiving opioids. Reassess pain score, sedation score, respiratory rate, oxygen saturation and urine output before escalation of analgesia. Severe, worsening or atypical pain should prompt clinical reassessment to exclude haemorrhage, sepsis, urinary retention, urinary tract injury, bowel injury, wound haematoma or thromboembolism.
5. DexamethasoneUnless contraindicated, give dexamethasone 8 mg IV after delivery as part of multimodal analgesia and postoperative nausea and vomiting reduction. For women with diabetes or gestational diabetes, monitor capillary blood glucose postoperatively and manage according to the postpartum diabetes plan.
For LSCS under general anaesthesiaThe transversus abdominis plane block (TAP block) represents a suitable regional analgesic modality following LSCS under general anaesthesia. Local anaesthetic wound infiltration serves as a practical alternative.

6.4 Early mobilisation and VTE prevention

6.5 Urinary catheter and bladder care

6.6 Wound care and hygiene

Table 14
AreaStandard
DressingKeep the wound clean and dry. For standard dressings, remove between 18 - 24 hours after caesarean birth according to wound condition and local policy.
High BMI / high wound-riskConsider negative-pressure wound therapy after caesarean birth for women with BMI ≥ 35 kg/m² to reduce wound infection risk
Daily reviewMonitor for fever, increasing pain, redness, swelling, discharge, separation or dehiscence.
Patient adviceWear loose clothing and cotton underwear. Clean with water and soap and dry the wound daily after dressing removal.
Suture/clip removalPlan removal if non-absorbable sutures or clips are used.

6.7 Fluid, nutrition and glycaemic care

6.8 Breastfeeding, bonding and neonatal care

Prior to LSCS neonatal preparedness must include:

Post LSCS neonatal care includes:

6.9 Education and discharge planning

Discharge readiness requires both clinical stability and clear safety-netting. Women recovering well, apyrexial and without complications may be suitable for discharge after 24 hours where;

Table 15
Discharge domainMinimum discharge content
Clinical stabilityStable vital signs, controlled pain on oral medication, no excessive bleeding, uterus well contracted, mobilising safely, tolerating oral intake and no unresolved anaesthetic/surgical concern.
Wound and hygieneWritten and verbal wound-care instructions, red-flag symptoms and plan for suture/clip removal if needed.
MedicinesAnalgesics with breastfeeding advice, VTE prophylaxis if prescribed, antihypertensives/diabetes medication changes and constipation/antiemetic plan if needed.
Warning symptomsReturn urgently for heavy bleeding, fever, worsening abdominal/wound pain, offensive lochia, wound discharge/separation, chest pain, breathlessness, calf swelling/pain, severe headache, visual symptoms, seizures, collapse, difficulty passing urine or concern about the baby.
Follow-upPostnatal follow-up plan, blood-test follow-up when required, infant follow-up, contraception plan and future-birth counselling after emergency/unplanned LSCS.

6.10 Mental health considerations

7. Escalation criteria

Table 16
Escalate urgently if any of the following are presentSuggested immediate action
MEOWS red trigger or persistent yellow triggers (Annexure 4).Call senior obstetrician, anaesthetist, senior obstetrics trainee or senior house officer and recovery/ward senior nurse; initiate ABCDE assessment; consider HDU/ICU.
Excessive vaginal bleeding, boggy uterus, rising fundus, symptomatic anaemia or suspected intra-abdominal bleeding.Manage as PPH/haemorrhage; obtain IV access, blood tests, crossmatch, uterotonics, tranexamic acid and senior review.
Fever, uterine tenderness, offensive lochia, wound cellulitis/discharge or sepsis concern.Sepsis screen, cultures as indicated, IV antibiotics according to local protocol and senior review.
Severe, worsening or atypical pain not responding to prescribed analgesia.Full reassessment to exclude haemorrhage, sepsis, urinary retention/injury, bowel injury, wound haematoma or thromboembolism.
Chest pain, breathlessness, haemoptysis, unilateral painful swollen calf, unexplained tachycardia or hypoxia.Suspected VTE pathway; urgent medical/anaesthetic/obstetric review and imaging/anticoagulation decision according to protocol.
Difficulty voiding after catheter removal, haematuria, oliguria or suspected urinary tract injury.Assess bladder volume, renal function and fluid balance; re-catheterise if retention; senior review.

8. Documentation, handover and audit indicators

8.1 Mandatory documentation

VTE risk assessment and prophylaxis plan.

WHO checklist completion and theatre sign-out.

8.2 Practical audit indicators

Table 17
IndicatorNumerator / denominatorSuggested target
Documented indication and urgency categoryNumber with documented indication and urgency / all LSCS>=95%
Risk stratification completedNumber with documented surgical risk level / all elective and non-crash LSCS>=90%
Consent documentedNumber with documented consent discussion / all non-crash LSCS>=95%
Antibiotics before skin incisionNumber receiving prophylaxis before incision / all LSCS>=100%
WHO checklist completedNumber with completed sign-in, time-out and sign-out>=95%
VTE assessment documentedNumber with VTE risk assessment / all LSCS>=95%
Postoperative observations completedNumber with MEOWS/local recovery observations completed / all LSCS>=95%
Wound-care and discharge advice documentedNumber with documented advice / women discharged after LSCS>=90%

9. Annexures

This table should be used as a counselling aid, not as a substitute for individualised risk assessment. Individual risks vary according to clinical indication, urgency, previous surgery, placental site, comorbidities, anaesthetic risk and neonatal factors.

Table 18
Comparative categoryExamples
Risk associated with caesarean birth.Maternal: Major abdominal surgery - risks include bleeding, infection, blood clots (DVT). Injury to bladder, ureter, or bowel (rare but possible). Longer home recovery - 6–8 weeks before return to full activity. Uterine scar affects all future pregnancies (placenta praevia, uterine rupture risk). Each subsequent caesarean becomes technically more difficult. Adhesions (internal scarring) - may cause future pain or surgical difficulty. Increased risk of DVT / pulmonary embolism. Neonatal: Transient tachypnoea of the newborn (TTN / “wet lung”); if LSCS performed at 39 weeks, this risk is reduced but not eliminated. Slightly higher chance of admission to Paediatric Baby Unit (PBU / SCBU). Small risk of accidental surgical nick to baby’s skin during uterine incision (rare).
Benefits of caesarean birthMaternal: Planned, predictable timing, reduces anxiety about labour Avoids risk of labour-related perineal injury. Lower risk of urinary incontinence immediately after birth. Avoids risk of emergency caesarean May be the preferred option for certain medical conditions. Neonatal: Avoid neaonatal trauma from instrumental deliveries. Low risk of meconium aspiration syndrome.
Risk associated with vaginal birthMaternal: Perineal tears (1st–4th degree) or episiotomy. Pelvic floor damage - may contribute to later urinary or bowel leakage. Prolonged or obstructed labour may require an emergency caesarean. Instrumental delivery (forceps or ventouse) if progress is slow. Shoulder dystocia Perineal pain in the weeks after birth. If labour does not begin naturally, induction of labour may be needed. Risk of stillbirth (FDIU) increases gradually beyond 40–42 weeks while awaiting spontaneous labour. Neonatal: Meconium Aspiration Syndrome Rare risk of skull fracture or nerve injury with instrumental delivery. Shoulder dystocia can cause arm nerve injury (brachial plexus). Cord prolapse (rare but serious).
Benefits of vaginal birthMaternal: Hospital stay is usually shorter; home recovery is much quicker - most women return to normal activity within 1–2 weeks. No abdominal surgical scar or future scar-related complications. Lower risk of injury to bladder, bowel, or major blood vessels. Breastfeeding often easier to establish. No uterine scar - better for future pregnancies. Neonatal: Passage through birth canal helps clear fluid from baby’s lungs. Hormonal surges during labour help prepare baby’s lungs and stress response - reduced respiratory morbidity for the baby. Exposure to vaginal bacteria - may support baby’s gut microbiome and immunity.

Annexure 2. WHO Surgical Safety Checklist

Figure from Preoperative Assessment and Immediate Postoperative Care for Lower Segment Caesarean Section (LSCS)
Figure from the source guideline

Annexure 3. Urgency categories of LSCS

Table 19
CategoryDefinitionTypical clinical examplesPractical target
Category 1Immediate threat to life of mother or fetusCord prolapse, suspected uterine rupture, major placental abruption, persistent fetal bradycardiaImmediate LSCS; aim for birth as soon as possible, usually within 30 minutes
Category 2Maternal or fetal compromise, but not immediately life-threateningPathological CTG without persistent bradycardia, failed instrumental delivery, slow progress with fetal/maternal concern, worsening pre-eclampsia requiring urgent birthUrgent LSCS; aim for birth as soon as possible, usually within 75 minutes
Category 3No maternal or fetal compromise, but early birth is neededFailed induction without distress, previous LSCS in early labour, malpresentation in labour without compromiseEarly LSCS; but not emergency; timing based on theatre and clinical priorities
Category 4Birth timed to suit woman or healthcare providerElective repeat LSCS, planned LSCS for placenta praevia/accreta spectrum when stable, breech planned LSCSElective LSCS; at scheduled time

Annexure 4. Modified Early Obstetric Warning Signs Chart

Figure from Preoperative Assessment and Immediate Postoperative Care for Lower Segment Caesarean Section (LSCS)
Figure from the source guideline

10. References